KYMR

$107.39-2.48%website ↗⬇ financials (.py)

Kymera Therapeutics, Inc.

Market Cap

$8.8B

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.94

60mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

84.1

Price / TTM revenue

P/B

5.9

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Velocity Score

1.03x

Sell Rate (90d)

959.68/mo

Sell Baseline

2309.87/mo

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-10-01	2026-10-01	Mainolfi Nello	Director & Chief Executive Officer	Sale	30.0K	$113.80	$3.41M	666.6K	View
2026-09-04	2026-09-04	Adams Brian	Chief Legal Officer	Sale	6,371	$116.83	$744K	50.3K	View
2026-07-07	2026-07-07	Mainolfi Nello	Director & Chief Executive Officer	Sale	50.0K	$119.00	$5.95M	666.6K	View
2026-07-01	2026-07-02	Mainolfi Nello	Director & Chief Executive Officer	Sale	80.0K	$115.29	$9.22M	666.6K	View
2026-07-01	2026-07-02	Goodman Noah	Chief Business Officer	Sale	3,389	$114.29	$387K	47.2K	View

1–5 of 39

1 / 8

KYMR

Signals

Factor Profile

Reporting Insiders

Recent News

Kymera Therapeutics, Inc. (KYMR)

Factor Profile

Date	Insider	Type	Shares	Value
2026-10-01	Mainolfi Nello	S	5,506	$618,984.52
2026-10-01	Mainolfi Nello	S	3,525	$392,826
2026-10-01	Mainolfi Nello	S	262	$30,423.44
2026-10-01	Mainolfi Nello	S	8,230	$949,742
2026-10-01	Mainolfi Nello	S	7,601	$869,782.43